IL5 and asthma: By promoting eosinophil activity, this pathway increases the production of inflammatory cytokines, such as interleukin-4 (IL-4) and interleukin-5 (IL-5), in conditions such as asthma and chronic rhinosinusitis with nasal polyps (CRSwNP), contributing to chronic inflammation [14].